Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.

по Farace, F, Mathiot, C, Brandely, M, Tursz, T, Dorval, T, Pouillart, P, Triebel, F, Hercend, T, Fridman, W H
Опубликовано 1990

Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients

по Bradwell, A, Harding, S, Fourrier, N, Mathiot, C, Attal, M, Moreau, P, Harousseau, J-L, Avet-Loiseau, H
Опубликовано 2013

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

по Tartour, E., Dorval, T., Mosseri, V., Deneux, L., Mathiot, C., Brailly, H., Montero, F., Joyeux, I., Pouillart, P., Fridman, W. H.
Опубликовано 1994

Rift Valley fever outbreak, Mauritania, 1998: seroepidemiologic, virologic, entomologic, and zoologic investigations.

по Nabeth, P, Kane, Y, Abdalahi, M O, Diallo, M, Ndiaye, K, Ba, K, Schneegans, F, Sall, A A, Mathiot, C
Опубликовано 2001

Use of Reverse Transcriptase PCR in Early Diagnosis of Rift Valley Fever

по Sall, A. A., Macondo, E. A., Sène, O. K., Diagne, M., Sylla, R., Mondo, M., Girault, L., Marrama, L., Spiegel, A., Diallo, M., Bouloy, M., Mathiot, C.
Опубликовано 2002

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

по Tartour, E, Mehtali, M, Sastre-Garau, X, Joyeux, I, Mathiot, C, Pleau, J M, Squiban, P, Rochlitz, C, Courtney, M, Jantscheff, P, Herrmann, R, Pouillart, P, Fridman, W H, Dorval, T
Опубликовано 2000